John H. Tucker
2017
In 2017, John H. Tucker earned a total compensation of $2M as President and Chief Executive Officer at scPharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $264,550 |
|---|---|
| Option Awards | $1,335,465 |
| Salary | $380,014 |
| Other | $10,800 |
| Total | $1,990,829 |
Tucker received $1.3M in option awards, accounting for 67% of the total pay in 2017.
Tucker also received $264.6K in non-equity incentive plan, $380K in salary and $10.8K in other compensation.
Rankings
In 2017, John H. Tucker's compensation ranked 5,516th out of 14,666 executives tracked by ExecPay. In other words, Tucker earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,516 out of 14,666 | 62nd |
Division Manufacturing | 1,988 out of 5,772 | 66th |
Major group Chemicals And Allied Products | 604 out of 2,075 | 71st |
Industry group Drugs | 465 out of 1,731 | 73rd |
Industry Pharmaceutical Preparations | 363 out of 1,333 | 73rd |
Source: SEC filing on April 30, 2018.
Tucker's colleagues
We found three more compensation records of executives who worked with John H. Tucker at scPharmaceuticals in 2017.
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019